RT @cannasciOA: A Review of Scientific Evidence for THC:CBD Oromucosal Spray (#Nabiximols) in the Management of #ChronicPain https://t.co…
RT @cannasciOA: A Review of Scientific Evidence for THC:CBD Oromucosal Spray (#Nabiximols) in the Management of #ChronicPain https://t.co…
RT @cannasciOA: A Review of Scientific Evidence for THC:CBD Oromucosal Spray (#Nabiximols) in the Management of #ChronicPain https://t.co…
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (#Nabiximols) in the Management of #ChronicPain https://t.co/UpgSoP4nDU @JPainResearch #OpenAccess #OpenScience
RT @ElixirSymbol: Sativex/Nabiximols is a 1:1 #THC:#CBD oral spray approved for treating Multiple Sclerosis. However, researchers are now c…
RT @ElixirSymbol: Sativex/Nabiximols is a 1:1 #THC:#CBD oral spray approved for treating Multiple Sclerosis. However, researchers are now c…
RT @ElixirSymbol: Sativex/Nabiximols is a 1:1 #THC:#CBD oral spray approved for treating Multiple Sclerosis. However, researchers are now c…
RT @ElixirSymbol: Sativex/Nabiximols is a 1:1 #THC:#CBD oral spray approved for treating Multiple Sclerosis. However, researchers are now c…
Sativex/Nabiximols is a 1:1 #THC:#CBD oral spray approved for treating Multiple Sclerosis. However, researchers are now considering this #Cannabis-based medicine as a therapy for chronic pain. #Mmemberville https://t.co/JGGhpwOwFY
@JacquiChilds Further re pain: Another study considered the potential of Nabiximols to relieve pain. This is a prescription of ~1:1 THC:CBD (2.7 mg THC & 2.5 mg CBD per spray). If possible, ask your physician for a prescription. Alternatively, try a ~1
RT @LiquidLifeBC: Initially developed to treat multiple sclerosis, Sativex/Nabiximols (THC:CBD spray) may also be an effective general ther…
RT @LiquidLifeBC: Initially developed to treat multiple sclerosis, Sativex/Nabiximols (THC:CBD spray) may also be an effective general ther…
RT @LiquidLifeBC: Initially developed to treat multiple sclerosis, Sativex/Nabiximols (THC:CBD spray) may also be an effective general ther…
RT @LiquidLifeBC: Initially developed to treat multiple sclerosis, Sativex/Nabiximols (THC:CBD spray) may also be an effective general ther…
Initially developed to treat multiple sclerosis, Sativex/Nabiximols (THC:CBD spray) may also be an effective general therapy for chronic pain. #Cannabis #Mmemberville #THC #CBD https://t.co/JGGhpwOwFY
RT @SaulNutri: Aumentan el número de ensayos que tratan de evidenciar el potencial del CBD en el tratamiento del dolor crónico. Los resuta…
Aumentan el número de ensayos que tratan de evidenciar el potencial del CBD en el tratamiento del dolor crónico. Los resutados actuales se muestran optimistas al respecto, aunque hacen falta investigaciones más ambiciosas. https://t.co/i5R1gLEkdA
RT @cannasciOA: A Review of Scientific Evidence for THC:CBD Oromucosal Spray (#Nabiximols) in the Management of Chronic Pain #OpenAccess #…
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (#Nabiximols) in the Management of Chronic Pain #OpenAccess #OpenScience https://t.co/UpgSoOMMfk
RT @cannasciOA: A Review of Scientific Evidence for THC:CBD Oromucosal Spray (#Nabiximols) in the Management of #ChronicPain #OpenAccess…
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (#Nabiximols) in the Management of #ChronicPain #OpenAccess #OpenScience #MultipleSclerosis #NeuropathicPain #RCT https://t.co/UpgSoP4nDU
RT @LiquidLifeBC: As detailed in the following review, Nabiximols/Sativex (~1:1 spray of #THC and #CBD) reduces neuropathic pain and spasti…
RT @LiquidLifeBC: As detailed in the following review, Nabiximols/Sativex (~1:1 spray of #THC and #CBD) reduces neuropathic pain and spasti…
As detailed in the following review, Nabiximols/Sativex (~1:1 spray of #THC and #CBD) reduces neuropathic pain and spasticity in patients with multiple sclerosis. #Cannabis https://t.co/JGGhpx684y
RT @LiquidLifeBC: As detailed in the following review, Nabiximols/Sativex (~1:1 spray of #THC and #CBD) reduces neuropathic pain and spasti…
RT @LiquidLifeBC: As detailed in the following review, Nabiximols/Sativex (~1:1 spray of #THC and #CBD) reduces neuropathic pain and spasti…
As detailed in the following review, Nabiximols/Sativex (~1:1 spray of #THC and #CBD) reduces neuropathic pain and spasticity in patients with multiple sclerosis. #Cannabis https://t.co/JGGhpx684y
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximo | JPR @DovePress https://t.co/hGeCfiY5XN
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain. https://t.co/wRJQ7uRUwO
RT @Lambert_Usyd: A review on the therapeutic benefit of add-on #THC:#CBD (nabiximols) in managing #neuropathic #chronicpain. #medicalcanna…
RT @ProudyMan1: Useful pain nabiximols study informed by German data:registry experience - 2 years of consistent benefit for neuropathic pa…
RT @ProudyMan1: Useful pain nabiximols study informed by German data:registry experience - 2 years of consistent benefit for neuropathic pa…
RT @ProudyMan1: Useful pain nabiximols study informed by German data:registry experience - 2 years of consistent benefit for neuropathic pa…
RT @ProudyMan1: Useful pain nabiximols study informed by German data:registry experience - 2 years of consistent benefit for neuropathic pa…
RT @arnthorjon: A Review of Scientific Evidence for #THC:#CBD Oromucosal Spray (#Nabiximols) in the Management of Chronic #Pain https://t.c…
Clinical trials and observational days from the German Pain e-Registry suggests that 1:1 THC:CBD oromucosal spray (Sativex/nabiximols) may reduce chronic neuropathic pain. But, more specific clinical trials are needed. No data presented in youth or child
Useful pain nabiximols study informed by German data:registry experience - 2 years of consistent benefit for neuropathic pain, no evidence of dependence and positive improvement for co-morbid conditions such as anxiety/depression. @UnitedInCompas1 @TGAgova
RT @arnthorjon: A Review of Scientific Evidence for #THC:#CBD Oromucosal Spray (#Nabiximols) in the Management of Chronic #Pain https://t.c…
A Review of Scientific Evidence for #THC:#CBD Oromucosal Spray (#Nabiximols) in the Management of Chronic #Pain https://t.co/Teq7EWjHOZ
RT @Lambert_Usyd: A review on the therapeutic benefit of add-on #THC:#CBD (nabiximols) in managing #neuropathic #chronicpain. #medicalcanna…
A review on the therapeutic benefit of add-on #THC:#CBD (nabiximols) in managing #neuropathic #chronicpain. #medicalcannabis 🤕⚡🕊️ https://t.co/X4frfL6HzK
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximo | JPR @DovePress https://t.co/xHMraOeqbe